New York State Department of Financial Services Reapproves China Oceanwide’s Acquisition of Genworth Life Insurance

New York State Department of Financial Services reapproved a previous proposal for China Oceanwide Holdings Group Co. Ltd. (Oceanwide)’s acquisition of Genworth Life Insurance Company of New York (GLICNY). Genworth Financial, the parent company of Genworth Life Insurance, reported the news with Oceanwide on March 24. The New York State Department of Financial Services had […]

Read more...

Advanz Pharma Acquires Correvio Pharma

On March 16, Correvio Pharma Corp. (CORV) announced that the company signed an acquisition agreement with Advanz Pharma Corp. Limited (ADVZ). Advanz Pharma will pay approximately $76 million for all outstanding Correvio shares and will execute the acquisition through its wholly-owned subsidiary, Mercury Pharma Group Limited. Correvio is a specialty pharmaceutical company focusing on commercializing […]

Read more...

Heritage Financial’s Board of Directors Authorizes New Share Repurchase Program

On March 12, Heritage Financial Corporation (HFWA) announced that the company’s Board of Directors authorized a new share repurchase program. This new stock repurchase program follows one authorized in 2014 in which the company repurchased 1,512,600 shares of common stock. The new program allows Heritage Financial to repurchase approximately 1.8 million shares, or up to […]

Read more...

February 2020 Scorecard

The February 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

Thermo Fisher Scientific Acquires Qiagen

On March 3, Thermo Fisher Scientific Inc. (TMO) and Qiagen N.V. (QGEN) announced that the Board of Directors from both companies approved Thermo Fisher’s proposal to acquire Qiagen. Under the terms of the agreement, Thermo Fisher will pay €39 per share in cash for Qiagen, which values the company at around $11.5 billion. Qiagen is […]

Read more...